China Chemical & Pharmaceutical Co., Ltd.

    China Chemical & Pharmaceutical Co., Ltd.

    TTWSE:1701
    21.15
    TWD
    0.00
    (0.00%)
    18.71P/E
    2011 Y
    2012 Y
    2013 Y
    2014 Y
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    TTM
    Revenue per Share
    16.9
    16.64
    17.41
    17.82
    18.93
    19.45
    21.01
    25.5
    26.81
    27.52
    26.74
    28.45
    28.85
    29.76
    Basic EPS, GAAP
    1.03
    1.09
    0.81
    1.17
    1.19
    1.05
    1.05
    1.24
    1.29
    1.88
    1.74
    1.61
    1.08
    1.19
    Free Cash Flow per Basic Share
    -2.33
    -1.46
    -1.29
    0.14
    0.83
    0.15
    1.01
    -0.22
    -0.55
    2.1
    1.64
    -0.35
    1.14
    1.06
    Dividend per Share
    0.7
    0.5
    0.5
    0.5
    0.6
    0.6
    0.6
    0.6
    0.8
    0.8
    1
    0.9
    0.8
    - -
    Book Value per Share
    12.26
    12.67
    14.61
    13.53
    13.94
    14.12
    14.47
    14.91
    15.32
    16.9
    19.51
    19.98
    20.16
    20
    Tangible Book Value per Share
    15.74
    15.97
    17.08
    18.41
    18.44
    18.38
    18.74
    19.07
    19.9
    22.2
    26.15
    24.92
    25.07
    24.92
    Basic Weighted Avg Shares
    297
    297
    297
    297
    297
    297
    297
    297
    297
    297
    297
    297
    297
    298
    Sales/Revenue/Turnover
    5,025
    4,948
    5,174
    5,297
    5,628
    5,781
    6,245
    7,580
    7,970
    8,181
    7,949
    8,457
    8,575
    8,871
    Operating Margin (%)
    5.61
    5.26
    4.54
    5.26
    4.37
    4.95
    4.44
    4.73
    4.86
    4.77
    5.18
    4.36
    2.78
    3.71
    Depreciation Expense
    156
    166
    194
    218
    249
    253
    255
    256
    258
    265
    277
    292
    314
    346
    Net Income, GAAP
    306
    324
    240
    348
    354
    313
    311
    370
    385
    557
    518
    478
    322
    355
    Effective Tax Rate (%)
    12.14
    16.98
    26.04
    19.01
    20.07
    18.46
    16.27
    18.54
    13.63
    14.92
    21.67
    18.58
    17.29
    19.83
    Profit Margin (%)
    6.09
    6.55
    4.65
    6.56
    6.28
    5.42
    4.98
    4.88
    4.83
    6.81
    6.51
    5.65
    3.76
    4
    Working Capital
    52
    1,368
    1,184
    1,737
    1,854
    1,897
    2,086
    2,308
    2,466
    2,615
    2,760
    2,639
    2,190
    1,751
    LT Debt
    - -
    1,475
    1,555
    1,625
    1,599
    1,640
    1,679
    1,828
    2,294
    2,111
    1,902
    1,803
    1,752
    1,122
    Total Equity
    4,691
    4,758
    5,089
    5,484
    5,489
    5,498
    5,604
    5,701
    5,939
    6,627
    7,788
    7,430
    7,470
    7,442
    Return on Invested Capital (%)
    3.65
    2.86
    2.15
    2.62
    2.3
    2.78
    2.72
    3.33
    3.61
    3.34
    3.05
    2.78
    1.82
    2.5
    Return on Capital (%)
    5.63
    5.44
    3.73
    5.07
    5.28
    4.78
    4.77
    5.42
    5.34
    7.03
    6.26
    5.65
    3.98
    4.5
    Return on Common Equity (%)
    8.45
    8.75
    5.93
    8.31
    8.66
    7.51
    7.31
    8.47
    8.56
    11.64
    9.56
    8.14
    5.4
    6.03

    Capital Structure

    TWD

    •

    in mil. unless spec.
    Dec'23
    Mar'24
    Jun'24
    ST Debt
    1,688
    2,072
    1,985
    LT Borrowings
    1,439
    1,109
    810
    LT Finance Leases
    314
    303
    312
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    298
    298
    298
    Market Capitalization
    7,087
    6,598
    6,644

    Working Capital

    TWD

    •

    in mil. unless spec.
    Dec'23
    Mar'24
    Jun'24
    Total Current Assets
    5,583
    5,573
    5,514
    Cash, Cash Equivalents & STI
    489
    511
    496
    Accounts Receivable, Net
    1,581
    1,556
    1,554
    Inventories
    2,585
    2,538
    2,519
    Total Current Liabilities
    3,393
    3,646
    3,763
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    1,688
    2,072
    1,985
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    TWD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    4.09%
    5.85%
    0.55%
    Free Cash Flow
    -14.69%
    -178.55%
    -427.65%
    Net Income, GAAP
    5.47%
    0.3%
    -32.51%
    Sales/Revenue/Turnover
    5.35%
    2.55%
    1.4%
    Total Cash Common Dividend
    - -
    - -
    -11.11%

    Quarterly Revenue

    TWD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    1,980
    2,080
    2,076
    2,320
    8,457
    2023
    2,096
    2,107
    2,096
    2,276
    8,575
    2024
    2,284
    2,216
    - -
    - -
    - -

    Quarterly Earnings Per Share

    TWD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    0.3
    0.52
    0.43
    - -
    1.61
    2023
    0.34
    0.18
    0.19
    - -
    1.08
    2024
    0.36
    0.27
    - -
    - -
    - -

    Quarterly Dividends Per Share

    TWD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    0.9
    2023
    - -
    - -
    - -
    - -
    0.8
    2024
    - -
    - -
    - -
    - -
    - -

    Company Description

    Company Profile APIChatGPT
    Address
    Similar Companies
    Business